Gan Lee receives EMA orphan drug designation for Phase I dru...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING, and BRIDGEWATER, N.J., April 6, 2021 /PRNewswire-AsiaNet/-- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products granted orphan d...
Authors: LATEST ASIANET NEWS RELEASES